We found that while the HepG2 tumours of PEG-IFN- and combination-treated animals showed significantly elevated p53 protein and mRNA levels, only the combination-treated tumours showed increased p53 phosphorylation at serine46 and elevated p53AIP1 mRNA levels. The gene discussed is IFNA1; the disease is neoplasm.